Advert Britannia

• Date posted
  01 February 2021
• Sanction
  Advertisement,
• Case number/s
  AUTH/3297/1/20 - Complainant v Britannia

Following the attendance of a member of the public at a Britannia symposium where Apo-Go (apomorphine for injection or infusion) was promoted, Britannia was ruled in breach of the following clauses of the Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 9.1 - Failing to maintain high standards

Clause 26.1 - Promoting a prescription only medicine to the public